Quantum Biopharma Stock Analysis
| QNTM Stock | 4.01 0.07 1.72% |
Quantum BioPharma is overvalued with Real Value of 3.84 and Hype Value of 3.73. The main objective of Quantum BioPharma stock analysis is to determine its intrinsic value, which is an estimate of what Quantum BioPharma is worth, separate from its market price. There are two main types of Quantum BioPharma's stock analysis: fundamental analysis and technical analysis.
The Quantum BioPharma stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Quantum BioPharma is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Quantum Stock trading window is adjusted to America/New York timezone.
Quantum |
Quantum Stock Analysis Notes
About 14.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.55. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Quantum BioPharma recorded a loss per share of 13.0. The entity had not issued any dividends in recent years. The firm had 1:65 split on the 15th of August 2024. To find out more about Quantum BioPharma learn more at https://www.quantumbiopharma.com.Quantum BioPharma Investment Alerts
| Quantum BioPharma had very high historical volatility over the last 90 days | |
| Quantum BioPharma has a very high chance of going through financial distress in the upcoming years | |
| Quantum BioPharma was previously known as HUGE Old and was traded on NASDAQ Exchange under the symbol HUGE. | |
| Net Loss for the year was (17.9 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Quantum BioPharma generates negative cash flow from operations | |
| Quantum BioPharma has a very weak financial position based on the latest SEC disclosures | |
| About 14.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Quantum BioPharma Makes Bold 1M Bitcoin Investment, Embraces Crypto for Future Transactions - StockTitan |
Quantum Largest EPS Surprises
Earnings surprises can significantly impact Quantum BioPharma's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-14 | 2024-06-30 | -3.9 | -5.2 | -1.3 | 33 | ||
2023-11-15 | 2023-09-30 | -9.1 | -1.95 | 7.15 | 78 |
Quantum Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.17 M.Management Efficiency
Quantum BioPharma has return on total asset (ROA) of (0.3612) % which means that it has lost $0.3612 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6389) %, meaning that it created substantial loss on money invested by shareholders. Quantum BioPharma's management efficiency ratios could be used to measure how well Quantum BioPharma manages its routine affairs as well as how well it operates its assets and liabilities. As of the 6th of January 2025, Intangible Assets is likely to grow to about 9.4 M, while Total Assets are likely to drop about 14.9 M.Understanding the operational decisions made by Quantum BioPharma management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Technical Drivers
As of the 6th of January, Quantum BioPharma holds the Coefficient Of Variation of 2145.63, risk adjusted performance of 0.0468, and Semi Deviation of 6.66. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Quantum BioPharma, as well as the relationship between them. Please check Quantum BioPharma variance, as well as the relationship between the value at risk and skewness to decide if Quantum BioPharma is priced some-what accurately, providing market reflects its current price of 4.01 per share. Given that Quantum BioPharma has jensen alpha of 0.3654, we recommend you to check out Quantum BioPharma's recent market performance to make sure the company can sustain itself at a future point.Quantum BioPharma Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Quantum BioPharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Quantum BioPharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Quantum BioPharma Predictive Daily Indicators
Quantum BioPharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Quantum BioPharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Quantum BioPharma Forecast Models
Quantum BioPharma's time-series forecasting models are one of many Quantum BioPharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Quantum BioPharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Quantum Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Quantum BioPharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Quantum shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Quantum BioPharma. By using and applying Quantum Stock analysis, traders can create a robust methodology for identifying Quantum entry and exit points for their positions.
Quantum BioPharma is entity of United States. It is traded as Stock on NASDAQ exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Quantum BioPharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quantum BioPharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quantum BioPharma. If investors know Quantum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quantum BioPharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Quantum BioPharma is measured differently than its book value, which is the value of Quantum that is recorded on the company's balance sheet. Investors also form their own opinion of Quantum BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Quantum BioPharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quantum BioPharma's market value can be influenced by many factors that don't directly affect Quantum BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quantum BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Quantum BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quantum BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.